Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Positron Emission Tomography as a Predictor of Response in Neoadjuvant Chemotherapy for Non-Small Cell Lung Cancer

NCT00227539 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT00227539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00227539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Positron Emission Tomography as a Predictor of Response in Neoadjuvant Chemotherapy for Non-Small Cell Lung Cancer
Lead sponsor
University of Washington
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2005
Completion date
November 30, 2013
Enrollment
25 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer